@Psychopharm

Official Journal of the European Behavioural Pharmacology Society @EurBehavPharm
#Psychopharm

[Bita Moghaddam بيتا مقدم @bita137]

and may I add that this is not a mere "delay" as many institutions are TERMINATING these otherwise active grants if the NoA is delayed by more than 30 days because they cannot afford to keep grant supported research personnel on payroll

[Yavin Shaham @yavinshaham]

Special issue of the month: Excellent @PsychopharmEBPS issue on social behavior & neuropsychiatric disorders (editors: Daniele Caprioli, @MarcoVenniro, Sam Golden & Christelle Baunez). This issue is based on the 2022 EBPS workshop dedicated to this topic
https://t.co/iDgBRxtHlv

[UCI Center for the Study of Cannabis @UCICannabis]

🌿 Is cannabis a psychedelic?

Dr. Daniele Piomelli dives into this fascinating question in our latest Science at the Source episode!

Watch the 20-min lecture now ➡️ https://t.co/Psw3JXaAMf

#CannabisResearch #Psychedelics #Neuroscience #ICAL

[connorhaggarty.bsky.social @ConnorHaggarty]

Cool new paper from the @PsychopharmEBPS @EurBehavPharm special issue showing presence of the C385A rs324420 polymorphism in the FAAH gene and higher levels of Anandamide are associated with greater PTSD severity in adolescents

https://t.co/3QmmtF3owe

[Jibran Khokhar @DrJKhokhar]

Happy to share @BryanJenkinsPhD latest work published in @PsychopharmEBPS: Cannabidiol (CBD) potentiates physiological and behavioral markers of hypothalamic–pituitary–adrenal (HPA) axis responsivity in female and male mice https://t.co/wnyQWIdt8j @Newman_lab @JKhokharLab collab

[connorhaggarty.bsky.social @ConnorHaggarty]

Paper 1 from our special issue "Stress, Trauma and Cannabinoids" in @PsychopharmEBPS is out now 😍 (@BrainsBeesBikes, @MayoOnTheBrain, @CBaunez)

[Yavin Shaham @yavinshaham]

Paper of the week: Our new @PsychopharmEBPS paper, led by Jennifer Bossert, on the effect of nociceptin receptor partial agonist & antagonist on heroin relapse in our rat model of opioid maintenance. Neither drug mimicked buprenorphine effect in the model
https://t.co/32JXWbA8dp

[@Psychopharm @PsychopharmEBPS]

Today is the first day of #EBPS2024 in beautiful Banff, Alberta! Excited to see a full day of talks on psychedelics, ketamine, hot topics, posters, and more!

[Eur Behav Pharm Soc. @EurBehavPharm]

CONGRATULATIONS to our class of 2024 Travel Awardees 🥳 #EBPS2024

These 18 recipients will be joining us in Banff and presenting a data blitz on day 1 of the workshop.

There is still time to sign up to attend before the September 9th deadline https://t.co/DKDyVWctsQ.

[Kate Wassum 🧠👩🏼‍🔬 @KateWassum]

🚨The UCLA Psychology Department is hiring!!! 🚨
The UCLA Psych department is recruiting a tenure-track Assistant, Associate, or Full Professor in Computational and Behavioral Neuroscience.
More info here: https://t.co/NQUdDgCsE7)
Applications are open now through October 31 🎃

[Stephen Mahler @svmahler]

Check out our new paper in @PsychopharmEBPS on changes in cognition & dopamine systems, and lack thereof, after adolescent THC in rats! Congrats @martydoesneuro, W key support from @dr_stan!

[Shelly Flagel @Flagel_Lab]

Happy that this manuscript - "The effect of corticosterone on the acquisition of Pavlovian conditioned approach behavior in rats is dependent on sex and vendor" - is now out in Hormones and Behavior. Open access article here... https://t.co/YjAWO2z5uF
and summary 🧵 below...

[Stephen Mahler @svmahler]

Klaus Miczek was a giant of Psychopharmacology: the field and the journal. R.I.P.
Here's an interview from 2022. He covers his transformative impact on the journal, evolution of the field, @PsychopharmEBPS v @npp_journal, writing/editing success, & more.
https://t.co/bsib3ctEXD

[Eur Behav Pharm Soc. @EurBehavPharm]

As a society, we are keen to promote the development of ECRs. With that in mind, we have a new blog series with papers of interest from our partner journal @psychopharmEBPS
Our first posts are on the new page, provided by me (@connorhaggarty) & @b_so_cool
https://t.co/pJR8MoXDdw

[connorhaggarty.bsky.social @ConnorHaggarty]

I started an “interesting papers” blog over at the @EurBehavPharm website with papers from @PsychopharmEBPS . Any interested students/postdocs/Asst Profs interested should contact me 😊

It is very likely this will develop over time so any other topics of interest let me know.

[Grant Glatfelter @gcglatfelter]

Out now in @PsychopharmEBPS

"Reinforcing effects of fentanyl analogs found in illicit drug markets"

https://t.co/IzKyy6uyMR

[Samuel F. Acuff, PhD @SamuelAcuff]

New paper in @PsychopharmEBPS: “Heterogeneity in choice models of addiction: the role of context” with fantastic team @juststrickland @field_matt @kirstenelins

Thrilled about this one. A thread below, but please go read it as well!

https://t.co/vVRWLfT7lI

[Leah Mayo @MayoOnTheBrain]

Our @PsychopharmEBPS Special Issue on Stress, Trauma, and Cannabinoids from the #EBPS2023 meeting is accepting submissions!

First deadline is Sept 1, 2024 ⌛️

Reach out to myself or any of the other editors for questions: @ConnorHaggarty, @BrainsBeesBikes @CBaunez

[Shelly Flagel @Flagel_Lab]

Review for @PsychopharmEBPS. When you click the "agree to review" link a PDF of the manuscript is automatically dowloaded AND they send you a calendar invite for when the review is due. Every journal should do this for reviewers.